InterSystems Wins Data Driven Product of the Year at the National Technology Awards

InterSystemsInterSystems, a provider of next-generation solutions for enterprise digital transformation to help customers solve the most critical data challenges, has announced it received the prestigious Data Driven Product of the Year award at this year's National Technology Awards.

The accolade recognises the power of InterSystems IRIS, the next generation data platform, and the tangible difference it makes to businesses across a wide variety of industries, from financial services and healthcare to logistics and supply chain.

A cloud-first data platform, InterSystems IRIS makes use of innovative technologies, such as IntegratedML, AutoML, and embedded analytics, to eliminate the need to implement and integrate multiple technologies. This results in less code, fewer system resources, less maintenance, and higher ROI for customers.

With high performance database management, interoperability, and analytics capabilities, all built-in from the ground up, InterSystems IRIS speeds and simplifies the most demanding data-intensive applications.

The annual National Technology Awards celebrates pioneers of technology and excellence. InterSystems UK&I Managing Director, Chris Norton, collected the award at the ceremony in London where the company had been shortlisted in an impressive four categories for both its InterSystems IRIS and InterSystems IRIS for Health data platforms.

Chris Norton, managing director UK&I, InterSystems, said: "We are honoured to have received the award for data driven product of the year for our InterSystems IRIS cloud-first data platform. We see every day how our innovative solutions allow our customers to extract insight at pace from ever-intensifying torrents of diverse, complex, and raw data to do everything from increasing efficiencies, agility, and resiliency, to improving customer experience and patient care, and creating new revenue streams. This award acknowledges that and the hard work and commitment of everyone at InterSystems to ensure both us and our solutions help our customers achieve their data ambitions."

About InterSystems

InterSystems is the engine behind the world’s most important applications. In healthcare, finance, government, and other sectors where lives and livelihoods are at stake, InterSystems is the power behind what mattersTM. Founded in 1978, InterSystems is a privately held company headquartered in Cambridge, Massachusetts (USA), with offices worldwide, and its software products are used daily by millions of people in more than 80 countries.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...